Sign in
4

Changes in Ownership

Beam Therapeutics Inc. Filed Acc 0001193125-25-230084

CEO sold 50,000 shares at an average $24.57 ($1,228,323)

  • CEO acquired 50,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Evans John M. CEO 2025-10-01 Option exercise 10b5-1 +25,000 $0.67 $16,750 1,011,667 D
Evans John M. CEO 2025-10-01 Sale 10b5-1 −25,000 $24.51 $612,655 986,667 D
Evans John M. CEO 2025-10-02 Option exercise 10b5-1 +25,000 $0.67 $16,750 1,011,667 D
Evans John M. CEO 2025-10-02 Sale 10b5-1 −25,000 $24.63 $615,668 986,667 D
Derivatives
Evans John M. CEO 2025-10-01 Option exercise · Stock Option (Right to Buy) 10b5-1 −25,000 44,336 D
Evans John M. CEO 2025-10-02 Option exercise · Stock Option (Right to Buy) 10b5-1 −25,000 19,336 D
Open-market sales · 50,000 sh · avg $24.57 · $1,228,323
Loading xslF345X05/ownership.xml…